After nearly forty years of prohibition, a new wave of research has emerged in the past decade exploring the efficacy of psychedelic substances (LSD, Ibogaine, Ayahuasca, MDMA, Psilocybin, and Cannabis) in the treatment of addictions, trauma, PTSD, end of life anxiety, and depression.